Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Microgen has registered a new vaccine for children against tick-borne encephalitis in Belarus
The children's vaccine Encevir Neo for the prevention of...
Solopharm has launched a new plant for the production of soft dosage forms
Solopharm, one of the leading pharmaceutical manufacturers in Russia,...
Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025
On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister...
ChemRar invests one billion rubles in a new plant for the production of pharmaceutical substances in Khimki
Construction is expected to be fully completed by the end of 2024, with full production start-up scheduled for Q1-Q2 2025.
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides
2026 marks not just the arrival of new therapies,...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
Gennady Schweigert and Pavel Mileiko acquire 50% stake in Nanolek LLC
Nanolek LLC informs about changes in the ownership structure:...
The EEC Council approved the Requirements to patient information leaflet
At its meeting held on January 21, the Eurasian Economic Commission's Council approved an amended version of the Requirements to Patient Information Leaflet and Summary of Product Characteristics.
Sale of Drugs in Foreign Packaging Allowed in Russia Until End of 2027
The Government of the Russian Federation has decided to...
Over 21,500 Illegal Online Pharmacies Blocked in 2025 Following Roszdravnadzor
The Russian healthcare regulator has summarized the results of...
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
Experts propose changes to the rules for regulating veterinary medicinal products in the EAEU
On February 25, a working meeting of experts was...
Recommendations on registering medical devices in EAEU adopted
On December 23, the Eurasian Economic Commission's Board meeting...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures
OSE Immunotherapeutics SA today announces that the Company is...
AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug...
AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research
Cerebras Systems, the pioneer in high performance artificial intelligence...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Microgen has registered a new vaccine for children against tick-borne encephalitis in Belarus
The children's vaccine Encevir Neo for the prevention of...
Solopharm has launched a new plant for the production of soft dosage forms
Solopharm, one of the leading pharmaceutical manufacturers in Russia,...
Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025
On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister...
ChemRar invests one billion rubles in a new plant for the production of pharmaceutical substances in Khimki
Construction is expected to be fully completed by the end of 2024, with full production start-up scheduled for Q1-Q2 2025.
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides
2026 marks not just the arrival of new therapies,...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
Gennady Schweigert and Pavel Mileiko acquire 50% stake in Nanolek LLC
Nanolek LLC informs about changes in the ownership structure:...
The EEC Council approved the Requirements to patient information leaflet
At its meeting held on January 21, the Eurasian Economic Commission's Council approved an amended version of the Requirements to Patient Information Leaflet and Summary of Product Characteristics.
Sale of Drugs in Foreign Packaging Allowed in Russia Until End of 2027
The Government of the Russian Federation has decided to...
Over 21,500 Illegal Online Pharmacies Blocked in 2025 Following Roszdravnadzor
The Russian healthcare regulator has summarized the results of...
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
Experts propose changes to the rules for regulating veterinary medicinal products in the EAEU
On February 25, a working meeting of experts was...
Recommendations on registering medical devices in EAEU adopted
On December 23, the Eurasian Economic Commission's Board meeting...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures
OSE Immunotherapeutics SA today announces that the Company is...
AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug...
AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research
Cerebras Systems, the pioneer in high performance artificial intelligence...
PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
Alikhanov: Russia Pharma Market Hits 2.2 Trillion RUB. Ministry to Fund Clinical Trials
Russian Minister of Industry and Trade Anton Alikhanov gave...
Sale of Drugs in Foreign Packaging Allowed in Russia Until End of 2027
The Government of the Russian Federation has decided to...
Pharmasyntez Receives Azerbaijan GMP Certificate and Summarizes 2025 Production Results
The press service of the Pharmasyntez Group has announced...
Russian Pharma Market: Key GMP Certification Trends
Pharmaceutical manufacturing is one of the most regulated industries...
Newsletter
Get important news delivered directly to your inbox and stay connected!
© PHARMPROM 2026